CD200 expression was remarkably increased in CD117+ myeloid naive cells, CD4+ T cells, T cells, activated T cells, CD56dimNK cells, and CD56briNK cells from AML-MRD samples compared with those from normal bone marrow samples. This evidence concerns the gene KIT and acute myeloid leukemia.